HR-8412-119
Referred to the House Committee on Energy and Commerce.
Sponsored by Sara Jacobs (D-CA)
What it does
This bill would direct the FDA to revise labeling regulations for powdered and liquid beverages marketed for children ages 12 to 36 months. It would prohibit these products from using the word "formula" or "infant formula" in their names, require descriptive common names (e.g., "milk-based drink" or "soy-based drink powder"), mandate warning labels about added sugars and age-appropriateness, and ban suggested daily intake statements. The FDA would have one year to propose regulations and two years to finalize them, with compliance required three years after enactment.
Who benefits
Parents and caregivers of children ages 12–36 months who may be misled by "formula"-style branding into purchasing products that are not nutritionally equivalent to infant formula. Pediatricians and dietitians who counsel families on toddler nutrition. Manufacturers of plain whole cow's milk and other beverages that compete with toddler drink products but do not use "formula" branding. Public health researchers and advocacy groups focused on early childhood nutrition. Lower-income families who may spend more on branded toddler drinks believing them to be medically necessary.
Who is hurt
Manufacturers of toddler transition drinks and "toddler formula" products (e.g., Enfagrow, Gerber Good Start Grow) who would need to reformulate packaging and marketing materials at their own cost. Retailers who carry these products and may face inventory and shelf-labeling disruptions during the transition period. Parents who currently rely on these products and may find the new labeling confusing during the adjustment period. Smaller or specialty beverage producers with fewer resources to absorb relabeling compliance costs.
Supporters argue
Supporters argue that toddler drinks are routinely marketed using "formula" branding that implies medical necessity or nutritional equivalence to infant formula — a claim that leading pediatric health organizations, including the American Academy of Pediatrics, have stated is unsupported. They contend that this branding misleads caregivers into spending money on products that are often high in added sugars and unnecessary for healthy toddler development, and that clear, standardized labeling would allow families to make genuinely informed purchasing decisions based on accurate product descriptions.
Opponents argue
Opponents argue that the FDA already has existing authority to address misleading food labeling and that a congressional mandate with hard regulatory deadlines — including a provision making proposed rules automatically final if deadlines are missed — bypasses the agency's normal notice-and-comment rulemaking process and could produce poorly calibrated regulations. They contend that the market for toddler transition beverages serves real consumer demand, particularly among families navigating breastfeeding cessation or dietary restrictions, and that prescriptive naming requirements may not account for the full diversity of products and their legitimate uses.
Constitutional context
Congress has broad authority to regulate food and beverage labeling under the Commerce Clause (Art. I, §8, cl. 3), as these products move in interstate commerce. The bill directs agency action rather than creating new mandates on individuals, so the activity/inactivity distinction from NFIB v. Sebelius (2012) is not implicated. Post-Loper Bright (2024), courts would independently review whether the FDA's implementing regulations stay within the statutory text of this bill and the Federal Food, Drug, and Cosmetic Act, rather than deferring to the agency's interpretation.
Checks and balances
The executive branch (FDA/HHS) gains a specific, congressionally directed rulemaking obligation; Congress checks that authority through the bill's hard deadlines and the automatic-finalization provision, while courts retain independent review of the final regulations under post-Loper Bright standards.
Historical precedent
The FDA's 2015 proposed rule on "infant formula" labeling and its 2023 guidance on toddler drink marketing addressed similar concerns administratively, but Congress has not previously enacted legislation directly mandating these specific labeling changes.